Cosmetic, Supplement, or Medical Device? The COFEPRIS Classification Guide for US Brands

The question keeping you up at night

You've done the research. Mexico's beauty and wellness market is growing fast, your product is selling well in the US, and someone on your team has already floated the idea of listing on Amazon Mexico. Then you searched "COFEPRIS classification" and found a wall of Spanish-language PDFs, outdated forum posts, and consultants quoting five-figure retainers before they'll even tell you what category you're in.

That's not paranoia, that's pattern recognition. Misclassify your product and you're looking at customs holds, recalled shipments, or a "free sale" that turns into anything but. I've seen founders burn six months of runway on a reclassification fight they could have avoided with a $1,000 preliminary opinion. The US playbook does not translate cleanly here, and the gap between what you assume and what COFEPRIS actually does is where the expensive surprises live.

This post covers what COFEPRIS says about each category, where the gray zones are, what it costs, and the specific mistakes that send founders back to square one.

---

What COFEPRIS classification actually means for your product

90% of US brands entering Mexico get their first classification decision wrong, not because they're careless, but because they assume the US regulatory framework maps onto Mexico's.

COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios) is Mexico's FDA equivalent, but the categories it uses are meaningfully different from what you're used to. A product that sits comfortably as an OTC supplement in the US might land in the "medicamento herbolario" (herbal medicine) bucket in Mexico, which triggers a completely different registration pathway, longer timeline, higher cost, and you can't sell a unit until it clears.

The four categories that matter most to US beauty and wellness brands:

1. Cosmético (cosmetic): products that alter appearance without physiological effect
2. Suplemento alimenticio (dietary supplement): food products with nutritional or functional claims
3. Medicamento herbolario (herbal medicine): plant-based products with therapeutic claims
4. Dispositivo médico (medical device): instruments, apparatus, or articles that diagnose, prevent, or treat

Your classification determines your regulatory pathway, your cost, your timeline, and whether certain label claims are even legal.

One thing to get out of your head right now: your FDA Certificate of Free Sale (CFS) is not a COFEPRIS approval. It doesn't transfer. It doesn't accelerate anything. It proves your product is legally sold in the US, which COFEPRIS may request as supporting documentation, but it does not substitute for a COFEPRIS registration or notice.

---

What the regulations actually say

Three separate legal instruments govern the classification decision, and most consultants only cite one.

The primary texts are the Ley General de Salud (General Health Law), the Reglamento de Control Sanitario de Productos y Servicios (RCSPS), and a series of Normas Oficiales Mexicanas (NOMs) that get into product-specific rules. You can find official versions of these instruments through gob.mx.

Cosméticos

A cosmético under Mexican law is any substance or mixture intended to be applied to external body parts (skin, hair, nails, lips, external genitalia, teeth, and mucous membranes) exclusively to clean, perfume, change appearance, correct odors, protect, or maintain them in good condition.

The operative word is "exclusively." The moment your label or marketing implies a physiological or therapeutic effect, COFEPRIS has grounds to reclassify your product. That word has killed more Mexico launches than any ingredient list.

Registration pathway: Cosméticos operate under "aviso de funcionamiento" (operating notice) plus product notification. This is a self-declaration system, not pre-market approval. You notify COFEPRIS, you comply with applicable NOMs, and you're eligible to sell. Faster and cheaper than full registration, for most beauty brands, this is the pathway you want to be in and the one you want to stay in. We break down that first filing in the aviso de funcionamiento guide.

Labeling standard: NOM-141-SSA1/SCFI-2012 governs cosmetic labeling. Your labels must be in Spanish, include a list of ingredients in INCI nomenclature (descending order), include net content, country of origin, and the name and address of the responsible party in Mexico. A local regulatory representative is not optional.

For beauty brands, this is where most of the action is. See the Mexico beauty market intelligence and the clean skincare market breakdown for what's actually selling on the shelf.

Suplementos alimenticios

This is where US supplement brands run into the most surprises. COFEPRIS defines a dietary supplement as a food product whose purpose is to supplement or complement the diet of a healthy individual, not to prevent, treat, or cure any disease.

That last clause is where deals die. "Supports joint health" might be fine. "Reduces joint inflammation" is a therapeutic claim, and COFEPRIS may classify the product as a medicamento. The line sounds clear until you're staring at your own copy trying to decide which side of it you're on.

Registration pathway: Suplementos require a "registro sanitario" (sanitary registration), not a simple notice. The dossier includes the "fórmula cuali-cuantitativa" (QQ formula, your complete ingredient list with quantities), an "análisis bromatológico" (nutritional analysis), stability studies, and label drafts. More work than the cosmético pathway, and it takes longer.

Claims rules: NOM-086-SSA1-1994 and subsequent guidelines govern claims on supplements. COFEPRIS maintains a positive list of permitted claims. If your claim isn't on that list, don't use it. The official COFEPRIS portal publishes current guidance on permitted claims and registration requirements.

For brands in the supplement space, the supplement-to-medicine classification line in Mexico is worth reading before you write a single word of copy, and the Mexico body care market report shows how the crossover beauty-supplement categories are positioned on price.

Medicamentos herbolarios

This is the bucket US brands most often fall into accidentally. If your product contains plant-derived ingredients and you're making health claims, COFEPRIS may classify it here rather than as a supplement. The distinction matters enormously: medicamentos herbolarios require full pre-market authorization, not just registration, and you cannot move a unit until that authorization is granted.

Timeline: 12 to 24 months. Cost: significantly higher. And there's no workaround, you're waiting.

If you're wondering whether your formulation might trigger this, the banned and restricted ingredients guide for Mexico is worth reading before you get too far down the compliance path.

Dispositivos médicos

Medical devices are the least common classification for D2C beauty and wellness brands, but they come up more than you'd expect. LED light therapy devices, microcurrent facial tools, certain skincare devices with claimed clinical effects, and anything with diagnostics language can land here.

COFEPRIS classifies medical devices into four risk classes (I through IV). Class I is lowest risk, Class IV is highest. A Class I device might clear in 30 to 60 days. A Class IV device could take 12 to 24 months and require clinical data.

The tell: your product "measures," "monitors," "corrects," "treats," or "improves" a medical condition, even a cosmetic one like acne, if it's phrased clinically.

---

Timeline and costs: planning benchmarks

The cost of getting classified correctly up front is roughly 10% of the cost of getting reclassified after launch. Here's what realistic timelines and costs look like across the four categories. Use these as planning benchmarks, not contractual estimates.

Table 1: COFEPRIS registration pathways by product category

The spread between the cosmético row and the medicamento herbolario row is the entire ballgame. A product that stays in the cosmético lane launches in about 6 weeks for a few thousand dollars. The same product, if a single claim on the label pushes it into the herbal-medicine bucket, disappears for up to two years and costs 5 to 10 times more. Nothing else in your Mexico launch has that kind of swing attached to one decision.

---

The mistakes that send founders back to square one

Roughly 5 recurring triggers account for the vast majority of reclassifications I see, and every one of them lives in the label copy, not the formulation.

The pattern is almost always the same: a brand takes label language that is completely legal in the US, translates it literally into Spanish, and hands COFEPRIS the grounds to move the product into a slower, more expensive category. The formula never changed. The words did. Below is the language map that decides which lane you land in.

Table 2: Label language that triggers reclassification

Three details are worth calling out. First, COFEPRIS reads your marketing, not just your label. Your Amazon MX listing copy, your product page, and your ad claims are all fair game, so a compliant label with an aggressive listing still gets you flagged. Second, the responsible party (responsable sanitario) has to be a Mexico-based legal entity or authorized representative, and there is no way around that requirement for a foreign brand. Third, once a product is flagged for reclassification, the burden is on you to prove it belongs in the lower category, which is far harder than picking the right lane from the start.

Getting the language right is not a copywriting exercise, it's a regulatory one. The words on your label are a classification argument, and COFEPRIS is the judge.

---

How to get your classification right before you ship

A $1,000 preliminary classification opinion is the cheapest insurance you will buy in your entire Mexico launch, and almost nobody buys it first.

Before you commit to a pathway, do three things. Run your exact product and its claims through a classification check so you know which of the four buckets you are actually in, rather than which one you hope you're in. You can start that self-assessment with the Mexico product scanner, which flags the claims and ingredients most likely to trigger a reclassification. If the answer is anything other than a clean cosmético, get a written preliminary opinion from a Mexico regulatory specialist before you print a single label.

Second, decide whether you're building this capability in-house or bringing in a partner who has run the COFEPRIS gauntlet before. The tradeoffs there are the same ones every brand faces, and we lay them out in Datahooks versus doing it yourself. For most first-time entrants, the classification stage is exactly where a wrong guess is most expensive and outside help pays for itself fastest.

Third, align your label and your marketing to the category you want before you file, not after you're flagged. If you're a beauty brand, the beauty brand playbook covers the claim language and NOM requirements specific to cosmetics. If you sit on the supplement side, the supplement brand playbook does the same for registros sanitarios and the claim positive-list.

Classification is not the exciting part of a Mexico launch. It's the part that quietly decides whether you're selling in 6 weeks or fighting COFEPRIS for 2 years. Pick the lane on purpose.